Galderma sells Alchemee unit to Taro

Switzerland-headquartered Galderma and US generics drugmaker Taro Pharmaceutical Industries (NYSE: TARO) have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company (TPC), from Galderma, a leading independent dermatology company.

The agreement between Galderma and Taro includes Alchemee’s business and assets around the world, including the Proactiv brand. Skin care product Proactiv has been used and trusted by millions around the world for more than 25 years. Originally set up as a subscription-based business, Proactiv quickly became a leading US consumer acne brand.

The acquisition is subject to customary closing conditions and any necessary regulatory approvals. Financial terms of the transaction have not been disclosed.